All Research
PAPER FIB4-CMeta-Analysis
Global bivariate meta-analysis of FIB-4 cut-offs to rule out advanced fibrosis in MASLD
Meta-analysis of 14 studies: FIB-4 <1.3 is a reliable, pragmatic first-line rule-out for advanced (stage >=F3) fibrosis in MASLD.
Evidence
8/10
Strong Evidence
Sample
—
subjects
Duration
—
study period
Journal
International Journal of Hepatology
02
Key Findings
- 01
FIB-4 <1.3 reliably rules out advanced (>=F3) fibrosis in MASLD
03
Structured Methods
- Study Design
- Meta-Analysis
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
04
Citations & References
Cite this paper
Unknown authors (n.d.). Global bivariate meta-analysis of FIB-4 cut-offs to rule out advanced fibrosis in MASLD. International Journal of Hepatology.
Source
Publisher
Journal
International Journal of Hepatology
PHS
671
/ 1000
T3
Longevity Operator
Sample member
Longevity Operator
The Peak Human Score · PHS v1
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation